BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial seeks better treatment for aggressive childhood cancer
Disease control OngoingThis study is for children and young adults (up to age 40) with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. It compares the current standard chemotherapy to the same chemotherapy plus a newer drug called temsirolimus. The goal is to see if adding temsirolimus hel…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for tough childhood cancers: major trial tests drug combo against aggressive muscle tumors
Disease control OngoingThis study compares two chemotherapy combinations for children and young adults with high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer. Researchers want to see if adding a drug called vinorelbine to standard treatment helps keep the cancer from returning better than…
Matched conditions: BOTRYOID-TYPE EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC